Womens Health Market .pdf
Original filename: Womens Health Market.pdf
This PDF 1.4 document has been generated by Online2PDF.com, and has been sent on pdf-archive.com on 20/04/2018 at 10:15, from IP address 1.23.x.x.
The current document download page has been viewed 295 times.
File size: 209 KB (8 pages).
Privacy: public file
Download original PDF file
Women’s Health Market
Global Industry Analysis, Trends, Market Size and Forecasts up to 2024
A latest report has been added to the wide database of Women’s Health Market by Infinium Global Research. This report studies the
Women’s Health Market by (hormonal, non-hormonal), diseases indication (hypothyroidism, osteoporosis, uterine fibroid, cancer, postmenopausal syndrome, contraceptive, urinary tract infection), distribution channel (online, hospital, retail pharmacy) market status and
outlook of global and major regions, from manufacturers, and end industries. The objective of the study is to identify market sizes of
different segments & countries in recent years and to forecast the values for the next six years. Women’s Health Market provides
opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape, latest trends, and
product offerings of the major companies in the Women’s Health Market. According to report the global women's health market was worth
USD 43.52 billion in 2016 and it is projected to reach USD 57.89 billion in 2023 growing at a CAGR of 5.72% over the forecast period of 20182024.
A woman has unique health issues such as pregnancy, menopause, and other diseases. The innovations in prescription drugs for women
health are used to treat a number of diseases and conditions in a variety of therapeutic areas. According to Health, about 52.3% of women
in age of 50 to 59 suffer from menopause uses antidepressant therapy. Growing female elderly population, unhealthy lifestyle, satisfactory
government strategies & initiatives by private organizations are some of the drivers that boost the market. Research and development for
innovation of new medicines for women is likely to surge this market. Additionally increasing awareness among society about the
availability of treatment for women’s health related diseases propel the growth of this market.Moreover, improving healthcare organization
in emerging markets and rising number of government approvals for immunoassay techniques provide substantial growth opportunities for
key players in the women health market.
The report on global women's health market covers segments such as, treatment type, diseases indication and distribution channel. On the
basis of treatment type the global women's health market is categorized into hormonal and non-hormonal. Combination therapy, thyroid
replacement therapy, estrogen therapy, progestin therapy, parathyroid hormone therapy, and others is sub segment of hormonal
treatment type. Cancer targeted therapy drugs, antibiotics, bisphosphonates, and others are included in non-hormonal treatment segment.
On the basis of diseases indication the global women's health market is categorized into hypothyroidism, osteoporosis, uterine fibroid,
cancer, post-menopausal syndrome, contraceptive, urinary tract infection and others. On the basis of distribution channel the global
women's health market is categorized into online pharmacy, hospital pharmacy and retail pharmacy.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this
section the key trends and market size for each geography is provided over the period of 2016-2024.
The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India,
South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region.
The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial
potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a
growth at a CAGR of x.x% over the period of 2018-2024.
Make an Enquiry
The report provides profiles of the companies in the global women's health market such as, Novartis AG, Merck & Co., Inc., Amgen Inc, Eli
Lilly and Company, Lupin Pharmaceuticals, Inc., Novo Nordisk A/S, AstraZeneca, Pfizer, Inc., Sanofi and Other. This industry feature for
merger and acquision as an explanations strategy for instance Ahmedabad-based Torrent Pharma has completed the acquisition of women
healthcare brands Regestrone and Pregachieve for India from Swiss pharma major Novartis AG.
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides
insights on the factors that are driving and restraining the global women's health market. Moreover, IGR-Growth Matrix analysis given in
the report brings an insight on the investment areas that existing or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO analysis of women's health market. Moreover, the study
highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the women's health
market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an
insight on the market share of the leading players. This report will help manufacturers, suppliers and distributors of the women's health
market to understand the present and future trends in this market and formulate their strategies accordingly.
Get a Sample Request
Table of Contents:1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Global Women’s Health Market Overview
3.2. Market Dynamics
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.5. Competitive Landscape in the Global Women’s Health Market
4. Global Women’s Health Market by Treatment Type
4.1.1. Combination Therapy
4.1.2. Parathyroid Hormone Therapy
4.1.3. Thyroid Replacement Therapy Estrogen Therapy
4.1.4. Progestin Therapy
4.2.1. Targeted Therapy Drugs
5. Global Women’s Health Market by Diseases Indication
5.3. Uterine Fibroid
5.5. Post-Menopausal Syndrome
5.7. Urinary Tract Infection
6. Global Women’s Health Market by Distribution Channel
6.1. Online Pharmacy
6.2. Hospital Pharmacy
6.3. Retail Pharmacy
7. Global Women’s Health Market by Region 2018-2024
7.1. North America
7.1.1. North America Women’s Health Market by Treatment Type
7.1.2. North America Women’s Health Market by Diseases Indication
7.1.3. North America Women’s Health Market by Distribution Channel
7.1.4. North America Women’s Health Market by Country
7.2.1. Europe Women’s Health Market by Treatment Type
7.2.2. Europe Women’s Health Market by Diseases Indication
7.2.3. Europe Women’s Health Market by Distribution Channel
7.2.4. Europe Women’s Health Market by Country
7.3.1. Asia-Pacific Women’s Health Market by Treatment Type
7.3.2. Asia-Pacific Women’s Health Market by Diseases Indication
7.3.3. Asia-Pacific Women’s Health Market by Distribution Channel
7.3.4. Asia-Pacific Women’s Health Market by Country
7.4.1. RoW Women’s Health Market by Treatment Type
7.4.2. RoW Women’s Health Market by Diseases Indication
7.4.3. RoW Women’s Health Market by Distribution Channel
7.4.4. RoW Women’s Health Market by Sub-region
8. Company Covered
8.1. Novartis AG
8.2. Merck & Co., Inc.
8.3. Amgen Inc
8.4. Eli Lilly and Company
8.5. Lupin Pharmaceuticals, Inc.
8.6. Novo Nordisk A/S
8.8. Pfizer, Inc.
Click the Below Full Report Link